Featured Articles

The June 2015 issue of BJS is now available online

Click here to access the latest issue of BJS. Includes FREE access to the Leading Article entitled 'Surgical treatment for portal hypertension" by M. A. Mercado. Additionally, available as OPEN ACCESS is an Original Article entitled 'Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor ß signal activation and liver regeneration after hepatectomy in an experimental model' by H. Kuroki, H. Hayashi, S. Nakagawa et al.

Read Society meeting abstract supplements

Click here to read abstracts from the annual meetings of SARS, ASGBI, SEIQ, the Swiss Society of Surgery and others.

Scientific Surgery

Featuring updated taxonomy to make it more intuitive and searchable, this database of randomized clinical trials in surgery allows you to browse by subject or search by date, making Scientific Surgery your first stop for surgical RCTs.

From The Journal

Highlights from the Journal

Volume 102 Issue 7 (June 2015) is now available online

Journal cover

Click here to access the Table of Contents.

To access articles published as Early View in advance of inclusion in an issue, please click here.

- Remember we now publish Spanish translations of all abstracts; they can be found in the translation section at the end of each issue. Recuerde que la traducción al español de todos los resúmenes la encontrará en la sección correspondiente al final de cada número.

 - If you subscribe to BJS you can access content on the BJS app for iPad, iPhone and iPod Touch (instructions for syncing are available here).

Highlights of the June 2015 issue

- Surgical treatment for portal hypertension.  M. A. Mercado

- RCT of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection.  M. Shimoda. K. Kubota, T. Shimizu and M. Katoh

- Anatomical versus non-anatomical resection for hepatocellular carcinoma.  S. Marubashi, K. Gotoh, H. Akita, H. Takahashi, Y. Ito, M. Yano, O. Ishikawa and M. Sakon

- Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction.  P. Starlinger, S. Haegele, D. Wanek, S. Zikeli, D. Schauer, L. Alidzanovic et al.

Your Views

Recent Articles

MRI in living‐donor liver transplantation">Functional assessment of the liver with gadolinium–ethoxybenzyl‐diethylenetriamine penta‐acetate‐enhanced MRI in living‐donor liver transplantation

Author:
M. Ninomiya, K. Shirabe, H. Kayashima, T. Ikegami, A. Nishie, N. Harimoto, Y. Yamashita, T. Yoshizumi, H. Uchiyama, Y. Maehara

Age‐specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population

Author:
D. P. J. Howard, A. Banerjee, J. F. Fairhead, A. Handa, L. E. Silver, P. M. Rothwell, 

Randomized clinical trial of mast cell inhibition in patients with a medium‐sized abdominal aortic aneurysm

Author:
H. Sillesen, N. Eldrup, R. Hultgren, J. Lindeman, K. Bredahl, M. Thompson, A. Wanhainen, U. Wingren, J. Swedenborg, 

Experimental study of fat grafting under negative pressure for wounds with exposed bone

Author:
H.‐K. Kao, H.‐H. Hsu, W.‐Y. Chuang, K.‐P. Chang, B. Chen, L. Guo

Latest Tweets from @bjsurgery

From the Clinical Media Library

Recent Podcasts

BJS podcast on treatment for primary varicose veins

J. Brittenden, B. Campbell and D. Carradice

BJS podcast on breast cancer

S. M. Pilgrim, S. Loibl and T. Sørlie

Latest image

Latest video

Personalized For You

This column will be specially populated with content you might find relevant based on your areas of interest.

Register or Login to get started

From the journal

Randomized clinical trial of mast cell inhibition in patients with a medium‐sized abdominal aortic aneurysm

Author:
H. Sillesen, N. Eldrup, R. Hultgren, J. Lindeman, K. Bredahl, M. Thompson, A. Wanhainen, U. Wingren, J. Swedenborg, 

Background Abdominal aortic aneurysm (AAA) is thought to develop as a result of inflammatory processes in the aortic wall. In particular, mast cells are believed to play a central role. The AORTA trial was undertaken to investigate whether the mast cell inhibitor, pemirolast, could retard the growth of medium‐sized AAAs. In preclinical and clinical trials, pemirolast has been shown to inhibit antigen‐induced...

From the clinical media library

From book reviews

Breast Disease Management

Author:
James Harvey, Sue Down, Rachel Bright-Thomas, John Winstanley, Hugh Bishop

This book provides a practical guide on how to investigate and manage common breast problems for all members of the breast disease team, whether surgeons, nurses, pathologists or support workers. Its focus is on providing easy access to the most up-to-date evidence, allowing healthcare workers to make the best decisions possible and encouraging a team approach to patient support. 26 chapters cover the whole of the patient journey from assessment through to surgery and adjuvant treatments, giving...

From the journal